{"id":59237,"date":"2026-06-04T22:30:43","date_gmt":"2026-06-04T13:30:43","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4880\/"},"modified":"2026-08-23T12:32:11","modified_gmt":"2026-08-23T03:32:11","slug":"company-4880","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4880\/","title":{"rendered":"CELLSOURCE CO LTD"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4880","DATE":"2026-01-09","longName":"CellSource Co., Ltd.","company_name_ja":"","fullTimeEmployees":148,"address":"","phone":"","website":"https:\/\/www.cellsource.co.jp","industry":"Biotechnology","sector":"Healthcare","regularMarketPrice":421,"financialCurrency":"","marketCap":8342,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0.54000000000000004,"epsForward":0,"bookValue":0,"totalRevenue":3711455000,"OperatingIncome":166708000,"operatingMargins":4.4900000000000002,"NetIncome":10659000,"profitMargins":0.28999999999999998,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0.17999999999999999,"recommendationMean":0,"recommendationKey":"none","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-08-01T03:59:20.754747\", \"ticker\": \"4880\", \"ticker_full\": \"4880.T\", \"company_name\": \"CELLSOURCE CO LTD\", \"analyst_recommendations\": {\"has_data\": true, \"period\": \"1\", \"strong_buy\": 0, \"buy\": 0, \"hold\": 0, \"sell\": 0, \"strong_sell\": 0, \"total_analysts\": 0, \"recommendation_key\": \"none\", \"recommendation_mean\": null}, \"target_prices\": {\"has_data\": true, \"current\": 322.0, \"high\": null, \"low\": null, \"mean\": null, \"median\": null}, \"earnings_dates\": {\"has_data\": false}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 54.27, \"institution_pct\": 4.04, \"major_holders\": [{\"label\": \"\", \"value\": 54.27}, {\"label\": \"\", \"value\": 4.04}, {\"label\": \"\", \"value\": 8.83}, {\"label\": \"\", \"value\": 18.0}], \"institutional_holders\": [], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"CellSource Co., Ltd. engages in the regenerative medicine-related businesses in Japan. The company provides processing services to extract adipose-derived stem cells from patients' adipose tissues, and to prepare platelet-rich plasma from patients' blood; and offers support services for medical facilities providing regenerative medicine therapy. It is also involved in the sale of human stem cell-derived cosmetic ingredients; and Signalift series of anti-aging products, including a serum. The company was incorporated in 2015 and is headquartered in Shibuya, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":5,"get_dividend_history_year2":5,"get_dividend_history_year3":20,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-23T02:06:03.445518\", \"ticker\": \"4880\", \"ticker_full\": \"4880.T\", \"company_name\": \"CELLSOURCE CO LTD\", \"company_info\": {\"name_en\": \"CELLSOURCE CO LTD\", \"long_name\": \"CellSource Co., Ltd.\", \"sector\": \"Healthcare\", \"industry\": \"Biotechnology\", \"website\": \"https:\/\/www.cellsource.co.jp\", \"employees\": 148, \"country\": \"Japan\", \"city\": \"Shibuya\", \"address\": \"SHIBUYA CAST.\", \"description\": \"CellSource Co., Ltd. engages in the regenerative medicine-related businesses in Japan. The company provides processing services to extract adipose-derived stem cells from patients' adipose tissues, and to prepare platelet-rich plasma from patients' blood; and offers support services for medical facilities providing regenerative medicine therapy. It is also involved in the sale of human stem cell-derived cosmetic ingredients; and Signalift series of anti-aging products, including a serum. The company was incorporated in 2015 and is headquartered in Shibuya, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 350.2, \"deviation\": 1.66, \"trend\": \"up\"}, \"ma_25\": {\"ma_value\": 329.88, \"deviation\": 7.92, \"trend\": \"up\"}, \"ma_75\": {\"ma_value\": 331.04, \"deviation\": 7.54, \"trend\": \"up\"}, \"ma_200\": {\"ma_value\": 388.78, \"deviation\": -8.43, \"trend\": \"down\"}}, \"financials\": {\"years\": [{\"year\": 2025, \"revenue\": 3711455000.0, \"revenue_fmt\": \"\u00a537\u5104\", \"gross_profit\": 2087476000.0, \"gross_profit_fmt\": \"\u00a521\u5104\", \"operating_income\": 166708000.0, \"operating_income_fmt\": \"\u00a52\u5104\", \"ebit\": 111160000.0, \"ebit_fmt\": \"\u00a51\u5104\", \"net_income\": 10659000.0, \"net_income_fmt\": \"\u00a510.7M\", \"eps\": 0.54, \"operating_margin\": 4.49, \"total_assets\": 7023969000.0, \"total_assets_fmt\": \"\u00a570\u5104\", \"total_equity\": 6016824000.0, \"total_equity_fmt\": \"\u00a560\u5104\", \"total_debt\": 56719000.0, \"total_debt_fmt\": \"\u00a556.7M\", \"total_cash\": 4711820000.0, \"total_cash_fmt\": \"\u00a547\u5104\", \"equity_ratio\": 85.66, \"de_ratio\": 0.01, \"current_ratio\": 12.39, \"operating_cf\": 333095000.0, \"operating_cf_fmt\": \"\u00a53\u5104\", \"investing_cf\": -3292000.0, \"investing_cf_fmt\": \"-\u00a53.3M\", \"financing_cf\": 61071000.0, \"financing_cf_fmt\": \"\u00a561.1M\", \"free_cf\": 282981000.0, \"free_cf_fmt\": \"\u00a53\u5104\", \"net_margin\": 0.29, \"roe\": 0.18, \"roa\": 0.15}, {\"year\": 2024, \"revenue\": 4355063000.0, \"revenue_fmt\": \"\u00a544\u5104\", \"gross_profit\": 2417411000.0, \"gross_profit_fmt\": \"\u00a524\u5104\", \"operating_income\": 129162000.0, \"operating_income_fmt\": \"\u00a51\u5104\", \"ebit\": 296303000.0, \"ebit_fmt\": \"\u00a53\u5104\", \"net_income\": 237940000.0, \"net_income_fmt\": \"\u00a52\u5104\", \"eps\": 11.96, \"operating_margin\": 2.97, \"total_assets\": 7074909000.0, \"total_assets_fmt\": \"\u00a571\u5104\", \"total_equity\": 6037100000.0, \"total_equity_fmt\": \"\u00a560\u5104\", \"total_debt\": 77290000.0, \"total_debt_fmt\": \"\u00a577.3M\", \"total_cash\": 4320915000.0, \"total_cash_fmt\": \"\u00a543\u5104\", \"equity_ratio\": 85.33, \"de_ratio\": 0.01, \"current_ratio\": 11.48, \"operating_cf\": 591723000.0, \"operating_cf_fmt\": \"\u00a56\u5104\", \"investing_cf\": -614961000.0, \"investing_cf_fmt\": \"-\u00a56\u5104\", \"financing_cf\": -437244000.0, \"financing_cf_fmt\": \"-\u00a54\u5104\", \"free_cf\": 52036000.0, \"free_cf_fmt\": \"\u00a552.0M\", \"net_margin\": 5.46, \"roe\": 3.94, \"roa\": 3.36}, {\"year\": 2023, \"revenue\": 4510544000.0, \"revenue_fmt\": \"\u00a545\u5104\", \"gross_profit\": 3185000000.0, \"gross_profit_fmt\": \"\u00a532\u5104\", \"operating_income\": 1221503000.0, \"operating_income_fmt\": \"\u00a512\u5104\", \"ebit\": 1240061000.0, \"ebit_fmt\": \"\u00a512\u5104\", \"net_income\": 923142000.0, \"net_income_fmt\": \"\u00a59\u5104\", \"eps\": 47.93, \"operating_margin\": 27.08, \"total_assets\": 6879736000.0, \"total_assets_fmt\": \"\u00a569\u5104\", \"total_equity\": 6201997000.0, \"total_equity_fmt\": \"\u00a562\u5104\", \"total_debt\": 97542000.0, \"total_debt_fmt\": \"\u00a597.5M\", \"total_cash\": 4781022000.0, \"total_cash_fmt\": \"\u00a548\u5104\", \"equity_ratio\": 90.15, \"de_ratio\": 0.02, \"current_ratio\": 12.36, \"operating_cf\": 846691000.0, \"operating_cf_fmt\": \"\u00a58\u5104\", \"investing_cf\": -624080000.0, \"investing_cf_fmt\": \"-\u00a56\u5104\", \"financing_cf\": 1449123000.0, \"financing_cf_fmt\": \"\u00a514\u5104\", \"free_cf\": 487689000.0, \"free_cf_fmt\": \"\u00a55\u5104\", \"net_margin\": 20.47, \"roe\": 14.88, \"roa\": 13.42}, {\"year\": 2022, \"revenue\": 4273829000.0, \"revenue_fmt\": \"\u00a543\u5104\", \"gross_profit\": 3064300000.0, \"gross_profit_fmt\": \"\u00a531\u5104\", \"operating_income\": 1571057000.0, \"operating_income_fmt\": \"\u00a516\u5104\", \"ebit\": 1583650000.0, \"ebit_fmt\": \"\u00a516\u5104\", \"net_income\": 1017842000.0, \"net_income_fmt\": \"\u00a510\u5104\", \"eps\": 52.98, \"operating_margin\": 36.76, \"total_assets\": 4599680000.0, \"total_assets_fmt\": \"\u00a546\u5104\", \"total_equity\": 3785529000.0, \"total_equity_fmt\": \"\u00a538\u5104\", \"total_debt\": 0.0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 3123580000.0, \"total_cash_fmt\": \"\u00a531\u5104\", \"equity_ratio\": 82.3, \"de_ratio\": 0.0, \"current_ratio\": 5.01, \"operating_cf\": 847603000.0, \"operating_cf_fmt\": \"\u00a58\u5104\", \"investing_cf\": -169388000.0, \"investing_cf_fmt\": \"-\u00a52\u5104\", \"financing_cf\": 14421000.0, \"financing_cf_fmt\": \"\u00a514.4M\", \"free_cf\": 748436000.0, \"free_cf_fmt\": \"\u00a57\u5104\", \"net_margin\": 23.82, \"roe\": 26.89, \"roa\": 22.13}, {\"year\": 2021, \"revenue\": 0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": 0, \"operating_income_fmt\": \"N\/A\", \"ebit\": 0, \"ebit_fmt\": \"N\/A\", \"net_income\": 0, \"net_income_fmt\": \"N\/A\", \"eps\": 0, \"operating_margin\": 0, \"total_assets\": 0, \"total_assets_fmt\": \"N\/A\", \"total_equity\": 0, \"total_equity_fmt\": \"N\/A\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 0, \"total_cash_fmt\": \"N\/A\", \"equity_ratio\": 0, \"de_ratio\": 0, \"current_ratio\": 0, \"operating_cf\": 0, \"operating_cf_fmt\": \"N\/A\", \"investing_cf\": 0, \"investing_cf_fmt\": \"N\/A\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": 0, \"free_cf_fmt\": \"N\/A\", \"net_margin\": 0, \"roe\": 0, \"roa\": 0}], \"has_data\": true}, \"dividends\": {\"history\": [{\"year\": 2023, \"amount\": 20.0}, {\"year\": 2024, \"amount\": 5.0}, {\"year\": 2025, \"amount\": 5.0}], \"latest\": 5.0, \"has_data\": true}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-59237","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>CELLSOURCE CO LTD - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4880\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4880\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4880\/\",\"name\":\"CELLSOURCE CO LTD - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-06-04T13:30:43+00:00\",\"dateModified\":\"2026-08-23T03:32:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4880\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4880\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4880\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CELLSOURCE CO LTD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CELLSOURCE CO LTD - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4880\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4880\/","url":"https:\/\/japanir.jp\/en\/company\/company-4880\/","name":"CELLSOURCE CO LTD - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-06-04T13:30:43+00:00","dateModified":"2026-08-23T03:32:11+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4880\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4880\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4880\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"CELLSOURCE CO LTD"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/59237","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=59237"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=59237"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}